Pub Date : 2020-01-01DOI: 10.5455/pcp.20200907082126
Dawei Chen, Jin Shi
The bilateral and symmetrical Wallerian degeneration (WD) of the middle cerebellar peduncles (MCPs) is rarely reported in pontine hemorrhage. We described a patient with WD of bilateral MCPs secondary to a strip of unilateral and transversal pontine hemorrhage. Magnetic Resonance Imaging showed hyperintensity on T2-weighted, fluid attenuation inversion recovery and diffusion weighted image, and hypointensity on T1-weighted and apparent diffusion co-efficient map, and no enhancement in bilateral MCPs. These abnormal signals existed over 6 months and subsided gradually. The patients didnt present with new symptoms when WD happened, the initial clinical manifestations related to pontine hemorrhage persisted for more than one year. In conclusion, a single unilateral pontine stroke along cross or trident line may cause WD of the bilateral MCPs in the below slice. Although this pathological change brings no additional new symptoms, it is related to the short‑term of poor neurological prognosis after pontine stroke. In addition, since this lesion appears restricted diffusion in the imaging, we should avoid misdiagnosing it as new infarction
{"title":"Wallerian Degeneration of the Bilateral Middle Cerebella Peduncles Secondary to Unilateral Pontine Hemorrhage","authors":"Dawei Chen, Jin Shi","doi":"10.5455/pcp.20200907082126","DOIUrl":"https://doi.org/10.5455/pcp.20200907082126","url":null,"abstract":"The bilateral and symmetrical Wallerian degeneration (WD) of the middle cerebellar peduncles (MCPs) is rarely reported in pontine hemorrhage. We described a patient with WD of bilateral MCPs secondary to a strip of unilateral and transversal pontine hemorrhage. Magnetic Resonance Imaging showed hyperintensity on T2-weighted, fluid attenuation inversion recovery and diffusion weighted image, and hypointensity on T1-weighted and apparent diffusion co-efficient map, and no enhancement in bilateral MCPs. These abnormal signals existed over 6 months and subsided gradually. The patients didnt present with new symptoms when WD happened, the initial clinical manifestations related to pontine hemorrhage persisted for more than one year. In conclusion, a single unilateral pontine stroke along cross or trident line may cause WD of the bilateral MCPs in the below slice. Although this pathological change brings no additional new symptoms, it is related to the short‑term of poor neurological prognosis after pontine stroke. In addition, since this lesion appears restricted diffusion in the imaging, we should avoid misdiagnosing it as new infarction","PeriodicalId":20847,"journal":{"name":"Psychiatry and Clinical Psychopharmacology","volume":"54 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90058084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.5455/pcp.20200316094036
O. Kilic, U. Yilmaz, Zeynep Komesli, A. Ercan, M. Çetiner
Mast cells are considered sensors of environmental and emotional stress, exist in all body parts and are related to the pathway from stress to inflamamation. Mastocytosis defines a rare disease, characterized by accumulation of abnormal mast cells in multiple organs. Here, we present a 77-year-old woman with a background of aggressive systemic mastocytosis who developed impaired cognition, depression, anxiety, visual hallucinations, delusions and insomnia. Symptoms alleviated only after initiating midostaurin, a tyrosine kinase inhibitor. Systemic mastocytosis should be kept in mind when visual hallucinations are concomitant with chronic or recurrent multi-system disturbances and do not benefit from treatment as usual.
{"title":"Can Visual Hallucinations be Among the Neuropsychological Manifestations of Systemic Mastocytosis?: A Geriatric Case","authors":"O. Kilic, U. Yilmaz, Zeynep Komesli, A. Ercan, M. Çetiner","doi":"10.5455/pcp.20200316094036","DOIUrl":"https://doi.org/10.5455/pcp.20200316094036","url":null,"abstract":"Mast cells are considered sensors of environmental and emotional stress, exist in all body parts and are related to the pathway from stress to inflamamation. Mastocytosis defines a rare disease, characterized by accumulation of abnormal mast cells in multiple organs. Here, we present a 77-year-old woman with a background of aggressive systemic mastocytosis who developed impaired cognition, depression, anxiety, visual hallucinations, delusions and insomnia. Symptoms alleviated only after initiating midostaurin, a tyrosine kinase inhibitor. Systemic mastocytosis should be kept in mind when visual hallucinations are concomitant with chronic or recurrent multi-system disturbances and do not benefit from treatment as usual.","PeriodicalId":20847,"journal":{"name":"Psychiatry and Clinical Psychopharmacology","volume":"1 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86424829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.5455/pcp.20200906091647
J. Kenar, E. Aydın, D. Aker, I. Altunay, Ömer Özer
Abstract Background: In this study, we aimed to perform the validity and reliability study for Turkish version of Skin Picking Impact Scale (SPIS). Methods: This study included 80 patients diagnosed with SPD according to DSM-5 diagnostic criteria. Patients were given Sociodemographic Data Form, Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Short Form-36 Quality of Life Scale (SF-36), Yale-Brown Obsessive Compulsive Scale Modified for Neurotic Excoriation (NE-YBOCS) and Turkish version of SPIS. Cronbachs alpha coefficient and item-total correlation were examined for the reliability of the scale. Confirmatory factor analysis (CFA) was used to examine the factor structure of the scale and ROC (Receiver Operating Characteristics) was performed to the discriminatory validity analysis. Results: Cronbachs alpha internal consistency coefficient was determined to be 0.942. Item-total correlation coefficients of all questions ranged between 0.665 and 0.849. The one-factor structure showed a good model fit in CFA. Good correlations were observed between SPIS and number of sites of picking (r=0.265, p=0.037), duration of skin picking per day (r=0.453, p
{"title":"Skin Picking Impact Scale: Reliability and Validity Study of Turkish Version","authors":"J. Kenar, E. Aydın, D. Aker, I. Altunay, Ömer Özer","doi":"10.5455/pcp.20200906091647","DOIUrl":"https://doi.org/10.5455/pcp.20200906091647","url":null,"abstract":"Abstract Background: In this study, we aimed to perform the validity and reliability study for Turkish version of Skin Picking Impact Scale (SPIS). Methods: This study included 80 patients diagnosed with SPD according to DSM-5 diagnostic criteria. Patients were given Sociodemographic Data Form, Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Short Form-36 Quality of Life Scale (SF-36), Yale-Brown Obsessive Compulsive Scale Modified for Neurotic Excoriation (NE-YBOCS) and Turkish version of SPIS. Cronbachs alpha coefficient and item-total correlation were examined for the reliability of the scale. Confirmatory factor analysis (CFA) was used to examine the factor structure of the scale and ROC (Receiver Operating Characteristics) was performed to the discriminatory validity analysis. Results: Cronbachs alpha internal consistency coefficient was determined to be 0.942. Item-total correlation coefficients of all questions ranged between 0.665 and 0.849. The one-factor structure showed a good model fit in CFA. Good correlations were observed between SPIS and number of sites of picking (r=0.265, p=0.037), duration of skin picking per day (r=0.453, p","PeriodicalId":20847,"journal":{"name":"Psychiatry and Clinical Psychopharmacology","volume":"35 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84525785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.5455/pcp.20201207094228
F. Aricioglu, M. Cetin
Sleeping has a critical function to promote health. Studies over the past ten years has documented that sleeping disorders has a strong influence on the risk of infectious diseases and in particular occurrence and progression associated with several major health issues including depression. Recent studies have focused on elucidating the underlying mechanisms that play a role in this situation. This article has been written to review the dynamics of sleep disturbance, sleep restriction, and insomnia on depression and the immune system. Also aimed to discuss the multi-faceted relationship that connect sleep disorder and immunity in terms of the neurobiology of sleep, inflammation and depression. In this context, what is known about the role of sleep on the immune system and the relationship between sleep disorder and depression and the immune system of depression will be reviewed.
{"title":"Exploring the Complex Relationship Between Sleep, Depression and the Immune System","authors":"F. Aricioglu, M. Cetin","doi":"10.5455/pcp.20201207094228","DOIUrl":"https://doi.org/10.5455/pcp.20201207094228","url":null,"abstract":"Sleeping has a critical function to promote health. Studies over the past ten years has documented that sleeping disorders has a strong influence on the risk of infectious diseases and in particular occurrence and progression associated with several major health issues including depression. Recent studies have focused on elucidating the underlying mechanisms that play a role in this situation. This article has been written to review the dynamics of sleep disturbance, sleep restriction, and insomnia on depression and the immune system. Also aimed to discuss the multi-faceted relationship that connect sleep disorder and immunity in terms of the neurobiology of sleep, inflammation and depression. In this context, what is known about the role of sleep on the immune system and the relationship between sleep disorder and depression and the immune system of depression will be reviewed.","PeriodicalId":20847,"journal":{"name":"Psychiatry and Clinical Psychopharmacology","volume":"8 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90187651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.5455/pcp.20200212074140
M. Tarakçıoğlu, M. Boysan, Yasin Caliskan, Ö. Demirel, N. C. Memik, M. Kadak
OBJECTIVE: The concept of thought-action fusion has long been recognized as a cognitive vulnerability factor for psyhopathology that given its clinical relevance and importance reliable assessment of this phenomenon seems to be essential. The aim of this study was to investigate the psychometric properties of the Thought-Action Fusion Inventory for Children (TAFIC) among Turkish children and adolescents. METHODS: Five hundred and ninety-one subjects (mean age=14.16±2.08 years) participated in the study. Voluntered subjects completed the TAFIC, Magical Ideation Scale (MIS), Child Depression Inventory (CDI), Screen for Child Anxiety Related Emotional Disorders RevisedChild Self-Report (SCARED-R-CV), and Metacognitions Questionnaire for Children (MCQ-C). RESULTS: Confirmatory factor analysis revealed the original four-factor structure excellently fit the data on the Turkish version of the TAFIC. Internal reliability of the instrument was acceptable to excellent, with Kuder-Richardson coefficients ranging from 0.70 to 0.89. The convergent validity of the TAFIC was adequate, with significant correlation coefficients with magical ideation, meta-cognitions, depression, and anxiety related emotional problems. CONCLUSIONS: Based on these findings, we concluded that the Turkish version of the TAFIC has promising psychometric properties in assessing thought-action fusion among children and adolescents.
{"title":"Psychometric properties of the Turkish version of the Thought-Action Fusion-Child Version (TAFIC)","authors":"M. Tarakçıoğlu, M. Boysan, Yasin Caliskan, Ö. Demirel, N. C. Memik, M. Kadak","doi":"10.5455/pcp.20200212074140","DOIUrl":"https://doi.org/10.5455/pcp.20200212074140","url":null,"abstract":"OBJECTIVE: The concept of thought-action fusion has long been recognized as a cognitive vulnerability factor for psyhopathology that given its clinical relevance and importance reliable assessment of this phenomenon seems to be essential. The aim of this study was to investigate the psychometric properties of the Thought-Action Fusion Inventory for Children (TAFIC) among Turkish children and adolescents. METHODS: Five hundred and ninety-one subjects (mean age=14.16±2.08 years) participated in the study. Voluntered subjects completed the TAFIC, Magical Ideation Scale (MIS), Child Depression Inventory (CDI), Screen for Child Anxiety Related Emotional Disorders RevisedChild Self-Report (SCARED-R-CV), and Metacognitions Questionnaire for Children (MCQ-C). RESULTS: Confirmatory factor analysis revealed the original four-factor structure excellently fit the data on the Turkish version of the TAFIC. Internal reliability of the instrument was acceptable to excellent, with Kuder-Richardson coefficients ranging from 0.70 to 0.89. The convergent validity of the TAFIC was adequate, with significant correlation coefficients with magical ideation, meta-cognitions, depression, and anxiety related emotional problems. CONCLUSIONS: Based on these findings, we concluded that the Turkish version of the TAFIC has promising psychometric properties in assessing thought-action fusion among children and adolescents.","PeriodicalId":20847,"journal":{"name":"Psychiatry and Clinical Psychopharmacology","volume":"142 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76745289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.5455/pcp.20200410093053
T. Charernboon
Background: Cognitive deficit is common and considered as the core feature of both mild cognitive impairment (MCI) and schizophrenia. However, only a few studies have directly compared cognitive profiles of these two conditions. The objective of the study was to compare the cognitive profiles of patients with schizophrenia to those with mild cognitive impairment (MCI). Methods: Participants consisted of three groups; 42 normal controls, 42 patients with schizophrenia and 42 people with MCI. They were matched 1:1:1 with comparable educational levels. Cognitive functions were assessed using the Addenbrookes Cognitive Examination III. Results: Recall memory and naming subdomains were significantly lower in the MCI group as compared to patients with schizophrenia, but did not differ on attention, verbal fluency, clock drawing test, language and visuospatial ability. Logistic regression and diagnostic prediction model demonstrated that the MCI group is best differentiated from the schizophrenia group using recall memory and naming scores. Conclusions: The cognitive profiles in patients with schizophrenia and MCI are different. In this study, naming and recall memory were less impaired in patients with schizophrenia than in people with MCI. The results of this study might provide some clues for clinicians on how to distinguish between
{"title":"Differentiating The Cognitive Impairment of Clinically Stable Schizophrenia from Mild Cognitive Impairment","authors":"T. Charernboon","doi":"10.5455/pcp.20200410093053","DOIUrl":"https://doi.org/10.5455/pcp.20200410093053","url":null,"abstract":"Background: Cognitive deficit is common and considered as the core feature of both mild cognitive impairment (MCI) and schizophrenia. However, only a few studies have directly compared cognitive profiles of these two conditions. The objective of the study was to compare the cognitive profiles of patients with schizophrenia to those with mild cognitive impairment (MCI). Methods: Participants consisted of three groups; 42 normal controls, 42 patients with schizophrenia and 42 people with MCI. They were matched 1:1:1 with comparable educational levels. Cognitive functions were assessed using the Addenbrookes Cognitive Examination III. Results: Recall memory and naming subdomains were significantly lower in the MCI group as compared to patients with schizophrenia, but did not differ on attention, verbal fluency, clock drawing test, language and visuospatial ability. Logistic regression and diagnostic prediction model demonstrated that the MCI group is best differentiated from the schizophrenia group using recall memory and naming scores. Conclusions: The cognitive profiles in patients with schizophrenia and MCI are different. In this study, naming and recall memory were less impaired in patients with schizophrenia than in people with MCI. The results of this study might provide some clues for clinicians on how to distinguish between","PeriodicalId":20847,"journal":{"name":"Psychiatry and Clinical Psychopharmacology","volume":"48 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81690759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.5455/pcp.20200429072430
C. Evren, H. Pontes, E. Dalbudak, B. Evren, M. Topçu, N. Kutlu
PURPOSE: Previous research on gaming disorder (GD) used psychometric tools, which evaluates according to the American Psychiatric Association (APA) diagnostic framework. The Gaming Disorder Test (GDT), a standardized measure to assess symptoms and prevalence of GD according to the World Health Organization (WHO) diagnostic framework. The main aim of the current study was to adapt GDT to Turkish. METHOD: In the present study participants were assessed with the GDT, the Internet Gaming Disorder ScaleShort-Form (IGDS9-SF), and the CAGE-Problematic Internet Use Questionnaire (CAGE-PIUQ). The factor structure of the scale was tested with Confirmatory Factor Analysis (CFA), and reliability and validity analyses were conducted. The method used in the study, and the scale adaptation, RESULTS: A sample of 932 Turkish gamers (58.3% male, mean age 23.64 years, SD=5.42) was recruited online. Confirmatory factor analyses demonstrated that the unidimensional factor structure of the GDT was satisfactory. The scale was also reliable (i.e., internally consistent with a Cronbach's alpha of 0.879) and showed adequate convergent and criterion-related validity, as indicated by statistically significant positive correlations between average time daily spent playing games (ATDSPG) during last year, IGDS9-SF and CAGE-PIUQ scores. By applying the International Classification of Diseases 11th edition (ICD-11) threshold for diagnosing GD (e.g., meeting all four criteria by answering them either with often [4] or very often [5]), it was found that the prevalence of GD is 1.9% (n = 18). CONCLUSION: Online gaming preference, ATDSPG and probable ADHD predicted the severity of disordered gaming. These findings support the Turkish version of the GDT as a valid and reliable tool for determining the extent of GD related problems among young adults and for the purposes of early GD diagnosis in clinical settings and similar research.
{"title":"Psychometric Validation of the Turkish Gaming Disorder Test: A Measure That Evaluates Disordered Gaming According to the World Health Organization Framework","authors":"C. Evren, H. Pontes, E. Dalbudak, B. Evren, M. Topçu, N. Kutlu","doi":"10.5455/pcp.20200429072430","DOIUrl":"https://doi.org/10.5455/pcp.20200429072430","url":null,"abstract":"PURPOSE: Previous research on gaming disorder (GD) used psychometric tools, which evaluates according to the American Psychiatric Association (APA) diagnostic framework. The Gaming Disorder Test (GDT), a standardized measure to assess symptoms and prevalence of GD according to the World Health Organization (WHO) diagnostic framework. The main aim of the current study was to adapt GDT to Turkish. METHOD: In the present study participants were assessed with the GDT, the Internet Gaming Disorder ScaleShort-Form (IGDS9-SF), and the CAGE-Problematic Internet Use Questionnaire (CAGE-PIUQ). The factor structure of the scale was tested with Confirmatory Factor Analysis (CFA), and reliability and validity analyses were conducted. The method used in the study, and the scale adaptation, RESULTS: A sample of 932 Turkish gamers (58.3% male, mean age 23.64 years, SD=5.42) was recruited online. Confirmatory factor analyses demonstrated that the unidimensional factor structure of the GDT was satisfactory. The scale was also reliable (i.e., internally consistent with a Cronbach's alpha of 0.879) and showed adequate convergent and criterion-related validity, as indicated by statistically significant positive correlations between average time daily spent playing games (ATDSPG) during last year, IGDS9-SF and CAGE-PIUQ scores. By applying the International Classification of Diseases 11th edition (ICD-11) threshold for diagnosing GD (e.g., meeting all four criteria by answering them either with often [4] or very often [5]), it was found that the prevalence of GD is 1.9% (n = 18). CONCLUSION: Online gaming preference, ATDSPG and probable ADHD predicted the severity of disordered gaming. These findings support the Turkish version of the GDT as a valid and reliable tool for determining the extent of GD related problems among young adults and for the purposes of early GD diagnosis in clinical settings and similar research.","PeriodicalId":20847,"journal":{"name":"Psychiatry and Clinical Psychopharmacology","volume":"54 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78916062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.5455/pcp.20201117083927
Z. Topal, I. Bahsi, A. Tufan
Background: Global scientific research output is continuously accelerating. Although psychiatric scientific output is increasing, factors such as health systems, scientific programs and financial supports that vary between countries lead to varied levels of contribution. This cross sectional bibliometric study aims to analysis the articles bibliometrically which conducted by researchers from Turkey and indexed in SCI-E index of the Web of Science (WoS)database in the category of Psychiatry. Methods: According to 2019 data, in the WoS database, journals in the Psychiatry category and indexed in the SCI-E were determined. Publications from Turkey that were published in these journals was determined. For each publication, all information relevant to the analysis was exported to Microsoft Excel and EndNote Desktop. Also, VOSviewer software was used to create a collaboration and word co-occurrence network. Results: There were 5293 publications which have at least one author from Turkey. Only 774 articles (14.62%) were written as international collaborations. The authors from Turkey were collaborating with the researchers from 66 diffrent countries and USA was leading these countries with 420 publications (%7.93), followed by England (3.3%) and Germany (2.4), respectively. The total number of citations was 53931 for these publications (mean: 10.19±22.51). The most prolific institution is Istanbul University while the most frequently selected journal by Turkish authors is Psychiatry and Clinical Psychopharmacology. Conclusion: Bibliometric studies are crucial in evaluating domain specific research and in planning for efficient use of limited resources. Psychiatric literature from Turkey greatly increased within the last two decades. However, international collaborations are still limited and most of the publications are in journals published in Turkey.
背景:全球科研产出持续加速增长。虽然精神病学的科学产出正在增加，但各国之间的卫生系统、科学规划和财政支持等因素的差异导致了不同程度的贡献。本横断面文献计量学研究的目的是对土耳其研究人员在Web of Science (WoS)数据库的SCI-E索引中收录的精神病学类文章进行文献计量学分析。方法:根据WoS数据库2019年的数据，确定SCI-E收录的精神病学类期刊。确定了土耳其在这些期刊上发表的出版物。对于每份出版物，所有与分析相关的信息都导出到Microsoft Excel和EndNote Desktop中。此外，使用VOSviewer软件创建协作和单词共现网络。结果:有1位作者来自土耳其的文献共5293篇。国际合作论文只有774篇(14.62%)。来自土耳其的作者与来自66个不同国家的研究人员合作，美国以420篇论文(%7.93)领先于这些国家，其次是英国(3.3%)和德国(2.4)。总被引次数为53931次(平均:10.19±22.51次)。最多产的机构是伊斯坦布尔大学，而土耳其作者最常选择的期刊是精神病学和临床精神药理学。结论:文献计量学研究对于评估特定领域的研究和规划有效利用有限资源至关重要。来自土耳其的精神病学文献在过去二十年中大大增加。然而，国际合作仍然有限，大多数出版物是在土耳其出版的期刊上发表的。
{"title":"Evaluation of The Psychiatric Research Output From Turkey Via Web Of Science Database: A Bibliometric Analysis","authors":"Z. Topal, I. Bahsi, A. Tufan","doi":"10.5455/pcp.20201117083927","DOIUrl":"https://doi.org/10.5455/pcp.20201117083927","url":null,"abstract":"Background: Global scientific research output is continuously accelerating. Although psychiatric scientific output is increasing, factors such as health systems, scientific programs and financial supports that vary between countries lead to varied levels of contribution. This cross sectional bibliometric study aims to analysis the articles bibliometrically which conducted by researchers from Turkey and indexed in SCI-E index of the Web of Science (WoS)database in the category of Psychiatry. Methods: According to 2019 data, in the WoS database, journals in the Psychiatry category and indexed in the SCI-E were determined. Publications from Turkey that were published in these journals was determined. For each publication, all information relevant to the analysis was exported to Microsoft Excel and EndNote Desktop. Also, VOSviewer software was used to create a collaboration and word co-occurrence network. Results: There were 5293 publications which have at least one author from Turkey. Only 774 articles (14.62%) were written as international collaborations. The authors from Turkey were collaborating with the researchers from 66 diffrent countries and USA was leading these countries with 420 publications (%7.93), followed by England (3.3%) and Germany (2.4), respectively. The total number of citations was 53931 for these publications (mean: 10.19±22.51). The most prolific institution is Istanbul University while the most frequently selected journal by Turkish authors is Psychiatry and Clinical Psychopharmacology. Conclusion: Bibliometric studies are crucial in evaluating domain specific research and in planning for efficient use of limited resources. Psychiatric literature from Turkey greatly increased within the last two decades. However, international collaborations are still limited and most of the publications are in journals published in Turkey.","PeriodicalId":20847,"journal":{"name":"Psychiatry and Clinical Psychopharmacology","volume":"47 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82682123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-10-02DOI: 10.1080/24750573.2019.1699738
Catherine Cheng, G. Baker, S. Dursun
ABSTRACT OBJECTIVE: Behavioral and psychological symptoms of dementia (BPSD) are a heterogeneous constellation of non-cognitive symptoms and behaviours that can cause significant patient distress and present complex management challenges. Behavioural and pharmacological treatments are used to decrease the symptoms, preserve function and increase quality of life. In the treatment of individuals with a major neurocognitive disorder, non-pharmacological interventions are often preferred as first-line treatment over pharmacological interventions, which often have modest efficacy, notable side effects and significant risks. Multisensory stimulation (MSS) interventions have become increasingly popular in the treatment of BPSD, particularly with disease progression. The objective of this review paper is to provide a brief overview of the types of MSS interventions currently used in the treatment of major neurocognitive disorders. METHODS: Searches for papers published in this area were conducted using PubMed and the Web of Science Core Collection. The searches were done for the period covering the past 20 years, and key phrases used were “multisensory stimulation for treatment of BPSD,” “multisensory stimulation for treatment of major cognitive disorders,” “multisensory stimulation for treatment of dementia” and “multisensory stimulation for treatment of neurodegenerative disorders.” RESULTS: Multisensory environments, multisensory tools and multisensory group therapies are discussed. There is growing support for the use of MSS interventions to improve mood, behaviour and quality of life in seniors with dementia and BPSD. However, currently the utilization of these interventions is highly variable and strong evidence for their use is limited. CONCLUSION: MSS interventions in the form of multisensory environments, tools and group therapies present tremendous potential as first-line treatments or as adjuncts to pharmacological interventions in the treatment of major neurocognitive disorders. However, the body of quality evidence that currently exists is limited. A lack of evidence does not necessarily mean a lack of efficacy, and there is a pressing need for studies with improved power and study design to determine the effectiveness of specific MSS interventions and to ascertain for whom they may be most beneficial.
目的:痴呆症的行为和心理症状(BPSD)是一种异质性的非认知症状和行为，可引起显著的患者痛苦，并提出复杂的管理挑战。行为和药物治疗用于减轻症状，保持功能和提高生活质量。在治疗患有严重神经认知障碍的个体时，非药物干预通常是首选的一线治疗方法，而不是药物干预，后者通常疗效一般，副作用明显，风险很大。多感觉刺激(MSS)干预在BPSD的治疗中越来越受欢迎，特别是在疾病进展时。这篇综述的目的是简要概述目前用于治疗主要神经认知障碍的MSS干预措施的类型。方法:使用PubMed和Web of Science Core Collection检索该领域发表的论文。这些搜索是在过去的20年里完成的，关键词是“治疗BPSD的多感觉刺激”，“治疗主要认知障碍的多感觉刺激”，“治疗痴呆的多感觉刺激”和“治疗神经退行性疾病的多感觉刺激”。结果:讨论了多感觉环境、多感觉工具和多感觉群体治疗。越来越多的人支持使用MSS干预措施来改善老年痴呆症和BPSD患者的情绪、行为和生活质量。然而，目前这些干预措施的使用是高度可变的，其使用的有力证据是有限的。结论:多感觉环境、工具和群体治疗形式的MSS干预在治疗重大神经认知障碍的一线治疗或辅助药物干预方面具有巨大的潜力。然而，目前存在的高质量证据是有限的。缺乏证据并不一定意味着缺乏疗效，迫切需要加强研究力度和研究设计，以确定特定的MSS干预措施的有效性，并确定这些干预措施可能对哪些人最有益。
{"title":"Use of multisensory stimulation interventions in the treatment of major neurocognitive disorders","authors":"Catherine Cheng, G. Baker, S. Dursun","doi":"10.1080/24750573.2019.1699738","DOIUrl":"https://doi.org/10.1080/24750573.2019.1699738","url":null,"abstract":"ABSTRACT OBJECTIVE: Behavioral and psychological symptoms of dementia (BPSD) are a heterogeneous constellation of non-cognitive symptoms and behaviours that can cause significant patient distress and present complex management challenges. Behavioural and pharmacological treatments are used to decrease the symptoms, preserve function and increase quality of life. In the treatment of individuals with a major neurocognitive disorder, non-pharmacological interventions are often preferred as first-line treatment over pharmacological interventions, which often have modest efficacy, notable side effects and significant risks. Multisensory stimulation (MSS) interventions have become increasingly popular in the treatment of BPSD, particularly with disease progression. The objective of this review paper is to provide a brief overview of the types of MSS interventions currently used in the treatment of major neurocognitive disorders. METHODS: Searches for papers published in this area were conducted using PubMed and the Web of Science Core Collection. The searches were done for the period covering the past 20 years, and key phrases used were “multisensory stimulation for treatment of BPSD,” “multisensory stimulation for treatment of major cognitive disorders,” “multisensory stimulation for treatment of dementia” and “multisensory stimulation for treatment of neurodegenerative disorders.” RESULTS: Multisensory environments, multisensory tools and multisensory group therapies are discussed. There is growing support for the use of MSS interventions to improve mood, behaviour and quality of life in seniors with dementia and BPSD. However, currently the utilization of these interventions is highly variable and strong evidence for their use is limited. CONCLUSION: MSS interventions in the form of multisensory environments, tools and group therapies present tremendous potential as first-line treatments or as adjuncts to pharmacological interventions in the treatment of major neurocognitive disorders. However, the body of quality evidence that currently exists is limited. A lack of evidence does not necessarily mean a lack of efficacy, and there is a pressing need for studies with improved power and study design to determine the effectiveness of specific MSS interventions and to ascertain for whom they may be most beneficial.","PeriodicalId":20847,"journal":{"name":"Psychiatry and Clinical Psychopharmacology","volume":"62 1","pages":"916 - 921"},"PeriodicalIF":0.7,"publicationDate":"2019-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84728807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-10-02DOI: 10.1080/24750573.2019.1695994
Seon-Cheol Park, Eun-Young Jang, Kiwon Kim, Hoseon Lee, Joonho Choi, Amitava Dan, A. Hussain, A. J. Tanra, Takahiro A. Kato, K. Chee, Sih-Ku Lin, Chay-Hoon Tan, A. Javed, N. Sartorius, N. Shinfuku, Y. Park
ABSTRACT Objective: Using data from the Research on Asian Psychotropic Prescription Patterns for Antipsychotics (REAP-AP), our study aimed to establish the remission and severity ranges (mild, moderate, and severe) of schizophrenia on the Brief Psychiatric Rating Scale-6 (BPRS-6). Methods: A total of 1,438 patients with schizophrenia from India, Indonesia, Japan, Malaysia, and Taiwan were enrolled in the study. Using the receiver operating characteristic (ROC) curve analyses, the optimal cut-off scores for the remission and severity ranges on the BPRS-6 were established. Results: The scalability of the BPRS-6 was considered to have an acceptable “unidimensionality” (coefficient of scalability = 0.43). The cut-off scores for the remission of schizophrenia and mild, moderate, and severe schizophrenia can be optimally defined as the BPRS-6 total score of <5, 5–9, 10–19 and >20, respectively. Conclusion: The BPRS-6 can be a promising, brief, and unidimensional rating scale to supplement the measurement-based care of schizophrenia.
{"title":"Establishing the cut-off scores for the severity ranges of schizophrenia on the BPRS-6 scale: findings from the REAP-AP","authors":"Seon-Cheol Park, Eun-Young Jang, Kiwon Kim, Hoseon Lee, Joonho Choi, Amitava Dan, A. Hussain, A. J. Tanra, Takahiro A. Kato, K. Chee, Sih-Ku Lin, Chay-Hoon Tan, A. Javed, N. Sartorius, N. Shinfuku, Y. Park","doi":"10.1080/24750573.2019.1695994","DOIUrl":"https://doi.org/10.1080/24750573.2019.1695994","url":null,"abstract":"ABSTRACT Objective: Using data from the Research on Asian Psychotropic Prescription Patterns for Antipsychotics (REAP-AP), our study aimed to establish the remission and severity ranges (mild, moderate, and severe) of schizophrenia on the Brief Psychiatric Rating Scale-6 (BPRS-6). Methods: A total of 1,438 patients with schizophrenia from India, Indonesia, Japan, Malaysia, and Taiwan were enrolled in the study. Using the receiver operating characteristic (ROC) curve analyses, the optimal cut-off scores for the remission and severity ranges on the BPRS-6 were established. Results: The scalability of the BPRS-6 was considered to have an acceptable “unidimensionality” (coefficient of scalability = 0.43). The cut-off scores for the remission of schizophrenia and mild, moderate, and severe schizophrenia can be optimally defined as the BPRS-6 total score of <5, 5–9, 10–19 and >20, respectively. Conclusion: The BPRS-6 can be a promising, brief, and unidimensional rating scale to supplement the measurement-based care of schizophrenia.","PeriodicalId":20847,"journal":{"name":"Psychiatry and Clinical Psychopharmacology","volume":"14 1","pages":"895 - 898"},"PeriodicalIF":0.7,"publicationDate":"2019-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88623952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：